9-hydroxy-4-phenyl-6H-pyrrolo[3,4-c]carbazole-1,3-dione

This compound is a synthetic small molecule belonging to the pyrrolocarbazole class of organic compounds. It features a tetracyclic core structure with hydroxy and phenyl substitutions and is primarily characterized as an experimental chemical entity with no current approved medical indications or known clinical development activity beyond early-stage research. Its mechanism of action and pharmacological targets have not been established in the literature or major drug databases as of June 2025.[1][2][6]

Other names

9-Hydroxy-4-phenylpyrrolo[3,4-c]carbazol-1,3(2H,6H)-dionePyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione, 9-hydroxy-4-phenyl-14-hydroxy-7-phenyl-4,10-diazatetracyclo[7.7.0.02,6.011,16]hexadeca‑1,6,8, 11(16),12‑14-hexaene‑3‑5-dione